comparemela.com

Latest Breaking News On - Haroon latif khan - Page 1 : comparemela.com

Treet : Right Issue (Final Offering Document) -October 30, 2023 at 01:25 am EDT

ADVICE FOR INVESTORS INVESTMENT IN EQUITY SECURITIES AND EQUITY RELATED SECURITIES INVOLVES A CERTAIN DEGREE OF RISKS. THE INVESTORS ARE.

New insights into how AI will lead to developments in assisted reproductive technology

New insights into how AI will lead to developments in assisted reproductive technology The 10 th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE) has provided exciting insights into likely developments and future possibilities in assisted reproductive technology including artificial intelligence. Since the first IVF baby was born in 1978, more than eight million babies have been delivered as a result of the assisted reproductive technique. In that time, there have been amazing advances in technology and treatment protocols to help the one in six couples living with infertility to fulfil their dreams of parenthood. One child in every 20 born today is an IVF baby, and another five per cent of babies around the world are conceived with the help of fertility drugs.

Insights in How AI Improves Fertility Treatment

Insights in How AI Improves Fertility Treatment by Angela Mohan on  May 12, 2021 at 11:36 AM ASPIRE has given new insights into future developments in assisted reproductive technology. Advances in technology and treatment protocols helped one in six couples living with infertility to fulfil their dreams of parenthood. The Congress was presented in virtual format to 3,285 fertility specialists in over 100 countries to share information on addressing the growing demand for assisted conception. Artificial intelligence (AI) was highlighted as one of the emerging technologies in fertility treatment. Dr Haroon Latif Khan provided details on how AI is being adopted in fertility clinics for stringent quality control measures to increase pregnancy and live birth success rates.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.